The Plum Duo is a dual-channel large-volume infusion pump from ICU Medical. The Plum Duo Precision IV Pump 510(k) summary lists intended routes of administration as intravenous, intra-arterial, and subcutaneous for parenteral fluids, medications, and whole blood and blood products, with intended populations of adult, pediatric, and neonatal patients [7]. The earlier Plum Duo Infusion System 510(k) summary describes intended use for parenteral fluids and medications through clinically acceptable routes limited to intravenous, intra-arterial, and subcutaneous therapies [3]. The specification sheet describes two channels, left and right, with each channel supporting a primary Line 1 and secondary Line 2 [1]. The K242115 summary describes the Plum Duo Precision IV Pump as having two independent pump channels that can deliver fluid to a patient from one to four lines independently [7]. ICU Medical's product page lists the Plum Solo and Plum Duo together under Plum Precision IV Pumps [2]. For hospital technology teams, the relevant questions concern documented specifications, therapy delivery modes, software dependencies, and the device's recent correction history. This guide answers those questions using primary documentation from ICU Medical and FDA records, including two Class 2 recall records with initiation dates in 2026, and offers a hypothetical evaluation scenario for teams comparing the Plum Duo against existing large-volume pump fleets.

Device Architecture and Delivery Specifications

The Plum Duo's physical design centers on two channels, described in the specification sheet as left and right, with each channel supporting a primary Line 1 and secondary Line 2 [1]. The device weighs approximately 10.6 pounds with battery and measures roughly 9 by 11.75 by 6.5 inches, excluding the pole clamp extrusion and power cord storage [1]. The specification sheet states the pump is intended for use in clinical environments in the hospital and other outpatient healthcare facilities by licensed healthcare professionals trained in the use of the infusion pump and the administration of therapies consistent with the intended use [1]. The K242115 summary adds that the environment of use excludes hyperbaric or oxygen-rich environments and MRI settings [7]. The casing is high-impact plastic, and the fluid ingress rating is IPX2, indicating protection against vertically falling water drops [1].

Delivery rate documentation shows a range of 0.1 to 999 mL per hour, with finer increments at lower rates: 0.01 mL per hour increments from 0.1 to 9.99 mL per hour, 0.1 mL per hour increments from 10 to 99.9 mL per hour, and 1 mL per hour increments from 100 to 999 mL per hour [1]. The specification sheet lists delivery accuracy of plus or minus 3 percent across the 0.1 to 999 mL per hour range, with testing performed in accordance with IEC 60601-2-24:2012 [1]. The K242115 summary for the Plum Duo Precision IV Pump lists flow rate delivery accuracy of plus or minus 3 percent for 0.1 to 999 mL per hour with 0 to 96 hours of cassette service, and bolus delivery accuracy of plus or minus 5 percent for delivery volumes as low as 0.1 mL at 999 mL per hour [7]. Concurrent delivery on the same side has a 0.5 mL per hour minimum per line and a 500 mL per hour cumulative maximum [1].

Therapy Modes and Clinical Workflow Distinctions

The K223607 510(k) summary for the Plum Duo Infusion System lists delivery methods including continuous, multistep, loading dose, and bolus, with loading dose and bolus available either standalone or with an underlying continuous therapy [3]. Therapy modes include piggyback with a flush feature, concurrent delivery, and deliver alone for primary delivery only [3]. The document notes that the piggyback flush feature automates a previously manual workflow and that deliver alone provides an option for medications that should not be interrupted or delivered concurrently with another medication or fluid [3]. These distinctions matter for teams evaluating how the device handles complex multi-infusion scenarios.

The comparison guide from ICU Medical places the Plum Duo alongside the Plum 360 and Plum Solo, showing 40 clinical care areas for all three devices, 1,000 medications per CCA for the Plum Solo and Plum Duo, and 400 for the Plum 360 [5]. The Plum Duo and Plum Solo both list 802.11 a/b/g/n/ac wireless standards, while the Plum 360 lists 802.11 a/b/g/n [5]. The comparison chart shows checkmarks for IV-EHR integration, auto-programming, and infusion documentation in the Plum Duo and Plum Solo columns, while the Plum 360 column does not show a checkmark for on-screen bar coding [5]. The chart does not indicate whether the absence of a checkmark means the feature is unavailable or simply not listed. These are documented feature listings, not independent performance findings.

Checking Recall Status for a Specific Unit

To check whether a specific Plum Duo unit is affected by the recall records, locate the UDI-DI and serial number on the device label. The first recall record lists UDI-DI M335400021 for Plum Duo Infusion Pump v1.2.3, item number 40002-0401 [6]. The second recall record lists item numbers 400020401 and 400020403 under UDI-DI +M335400021, with serial number ranges [8]. Compare the unit's serial number against the published lists in the FDA recall records. The first recall record lists Technical Support at 800-241-4002, extension 3 [6]. The second recall record lists Technical Support at 1-800-241-4002, option 3, or [email protected] [8]. The manufacturer's correction notices instruct facilities to identify affected pumps and ensure users are aware of the notification [6][8].

Regulatory Clearance and Recall History

The Plum Duo Infusion System 510(k) letter is dated August 24, 2023, under K223607, with product code FRN and regulation number 21 CFR 880.5725 [3]. A subsequent 510(k) letter, K242115, covers the Plum Duo Precision IV Pump and is dated April 2, 2025 [7]. The K242115 summary describes the device as having two independent pump channels that can deliver fluid to a patient from one to four lines independently [7]. The intended population is adult, pediatric, and neonatal patients, with the environment of use excluding hyperbaric or oxygen-rich environments and MRI settings [7].

Two Class 2 recall records appear in FDA's database. The first, with a date initiated by the firm of April 29, 2026 and a date posted of June 5, 2026, concerns the Plum Duo Infusion Pump v1.2.3, with 13,613 units in commerce and distribution listed as US nationwide in the states of ID, IL, IN, KS, MA, MD, NM, NY, PA, TN, TX and the country of Canada [6]. The manufacturer's stated reason is that under certain conditions the pump may not display a soft limit alert, and will not notify the clinician of a soft limit violation before confirming and starting delivery, which may potentially lead to under- or over-delivery [6]. The FDA determined the cause as a software design change [6]. A second recall record, with a page last updated date of November 16, 2026, describes a scenario in which the pump will not decrement the Volume to be Infused displayed on the Delivery screen and may deliver up to twice the VTBI at the programmed rate [8]. The correction notice instructs users not to press the Start button if the pump is in the state shown in the figures, to wait for the pump to complete the Cassette Test before taking further action, and to stop delivery and restart the line if the VTBI is not decrementing [8]. Both records show a recall status of open and classified [6][8].

Battery, Alarms, and Operational Limits

Battery documentation lists a lithium iron phosphate internal rechargeable battery at 12.8 volts and 3,000 mAh [1]. Typical battery operating time with a new and fully charged battery at nominal screen brightness is 6 hours 35 minutes for one channel at 25 mL per hour, 4 hours 25 minutes for one channel at 999 mL per hour, 5 hours 30 minutes for both channels at 25 mL per hour, and 3 hours for both channels at 999 mL per hour [1]. Recharge time is up to 8 hours, and the battery charges whenever the pump is connected to AC power and below maximum capacity [1].

Alarm documentation covers downstream and upstream occlusion, with a user-selectable downstream pressure limit ranging from 1 to 15 psi and a factory default setting of 6 psi [1]. The maximum infusion pressure is listed as 20 psi [1]. Air-in-line alarms are configured per clinical care area, with downstream air bolus settings of 50, 100, or 250 mL of air or larger and a cumulative threshold of 0.25 mL of air out of 4.9 mL of fluid [1]. Upstream air bolus alarm is 0.5 mL or larger, with a cumulative threshold of 1 mL, or 0.5 mL of air per line for concurrent delivery [1]. KVO defaults to 1.0 mL per hour or the last primary delivery rate, whichever is less, and may be configured by CCA from 1 to 20 mL per hour [1].

A Hypothetical Evaluation Workflow

A hospital technology team evaluating the Plum Duo against an existing Plum 360 fleet could structure a comparison around three documented decision points. First, the team would confirm whether the dual-channel architecture changes current pole configuration and line management practices, since each Plum Duo channel supports primary and secondary lines [1]. Second, the team would compare delivery accuracy documentation: the comparison guide lists the Plum 360 at plus or minus 10 percent from 0.1 to 0.9 mL per hour and plus or minus 5 percent from 1 to 999 mL per hour, while the Plum Duo is listed at plus or minus 3 percent across 0.1 to 999 mL per hour [5]. Third, the team would review the recall records for v1.2.3 and determine whether affected serial numbers are present in the fleet [6][8].

This hypothetical workflow is a suggestion for organizing an internal review, not a test protocol or a recommendation to adopt the device. Teams would still need to verify compatibility with their existing PlumSets, drug library configuration, wireless infrastructure, and EHR integration requirements through ICU Medical documentation and their own biomedical engineering review [4][5]. The recall records do not establish clinical harm rates, and the FDA database does not provide outcome data for the affected units [6][8]. Any procurement decision should be based on the facility's own risk assessment and clinical engineering standards.